Two large studies using DHA showed mixed results, with no benefit in people with mild to moderate Alzheimer's but a positive result in healthy older adults. The findings highlight the need for earlier detection and diagnosis of Alzheimer's disease, as well as further research on genetic interactions.
Researchers assessed the effectiveness of quetiapine in reducing agitation symptoms in Alzheimer's patients. A study also found a possible link between HIV treatment and increased risk of Alzheimer's disease due to abnormal protein deposits. An animal model has been developed to study tau protein tangles, a hallmark of Alzheimer's path...
Research suggests that genetics studies demonstrate a significant impact of environment on Alzheimer's disease. Low levels of education are also found to be a risk factor for all groups, including identical twins. Additionally, disclosing an Alzheimer susceptibility gene does not increase anxiety about developing the disease.
Researchers have developed strategies to target beta-amyloid, a substance thought to kill brain cells in Alzheimer's. Preliminary success has been achieved with a drug candidate that appears safe and effective in reducing amyloid levels.
African Americans bear a disproportionate burden of Alzheimer's disease, with early symptoms striking years before white peers. Studies reveal successful methods for involving minority communities in research to combat this growing public health threat.
Research suggests that managing blood pressure, cholesterol, blood sugar levels, and body weight can promote healthier aging and reduce Alzheimer's risk. Studies found a consistent increase in cognitive health with higher HDL (good) cholesterol levels and some hypertension medications associated with reduced Alzheimer's risk.
Recent advances in brain imaging may allow early diagnosis of Alzheimer's and other dementias, as well as improved assessment of treatment effectiveness. Researchers have developed new PET technologies to visualize abnormal protein accumulations in the brain, which may help differentiate between Alzheimer's and other forms of dementia.
The cost of care for those with Alzheimer's is projected to rise dramatically, with direct costs alone increasing by 60-200% as the disease progresses, and reaching $50 billion in less than 10 years.
Eating spinach and broccoli may slow cognitive decline; green leafy vegetables are associated with better brain health; complex leisure activities combining social, mental, and physical activity can prevent dementia.
A recent study demonstrated that a current Alzheimer drug may delay the transition from Mild Cognitive Impairment (MCI) to Alzheimer's disease, but only for the first 18 months. The treatment showed modest effects on progression to Alzheimer's, but more research is needed to confirm its efficacy.
Research on statins as a treatment for Alzheimer's disease has yielded conflicting results, with some studies showing improved cognitive function and others finding no benefit. Large-scale clinical trials are needed to resolve the questions raised by these studies.
The Alzheimer's Association and NIA are expediting prevention trials for Alzheimer's by developing more efficient tools, such as home-based testing. This will reduce costs and burdens on participants while gaining valuable information about the course of cognitive changes in late life.
A new animal model has been created to evaluate the effectiveness of an Alzheimer's vaccine, with promising results in clearing brain amyloid and reversing cognitive decline. The study involved vaccinating rhesus monkeys with beta-amyloid, a protein fragment suspected of disrupting nerve cells in the Alzheimer brain.
A study found that exercise combined with caregiver training can improve physical activity, reduce depression, and enhance physical health and function in people with Alzheimer's. Caregiver education also played a crucial role in the program's success.
A recent study suggests that menopause is not associated with an increase in cognitive decline, contrary to previous research. The Study of Women Across the Nation (SWAN) followed over 3,300 women across five ethnic groups, finding improved scores in most groups and minimal decline linked to menopause.
Researchers estimate that by mid-century, up to 16 million Americans will have Alzheimer's disease, with significant increases in prevalence among the oldest age group. Increasing funding for research is critical to prevent the disease or delay its onset and avoid devastating economic costs.
Recent studies establish that beta-amyloid activates caspases, cutting tau at its tangle-blocking end and generating abnormal filaments. This process occurs before neuronal apoptosis, promoting death of the neuron.
Women who developed Alzheimer's disease between ages 79 and 88 were significantly more likely to have been overweight at age 70. A moderate, healthy weight seems to be best according to the study.